Management of Alcoholic Pancreatitis
Acute Phase Management
- The American College of Gastroenterology recommends initiating goal-directed fluid therapy immediately upon presentation, targeting urine output >0.5 mL/kg/hour, using Ringer's lactate as the preferred crystalloid 1, 3
- Early oral feeding within 24 hours of presentation is recommended, rather than keeping the patient nil per os, to improve outcomes and shorten hospital stay 1, 2
- A multimodal analgesia approach with hydromorphone as the preferred opioid is recommended for pain management in non-intubated patients 1, 2, 3
Severity Assessment and Monitoring
- The American College of Gastroenterology recommends assessing severity using APACHE II scoring (cutoff of 8) to guide triage decisions 2
- For predicted severe disease (APACHE II >8), contrast-enhanced CT is recommended after 72 hours to evaluate for pancreatic necrosis 2
Management of Complications
- The American Gastroenterological Association recommends that sterile necrosis does not require therapy, and surgery has no role in sterile necrosis 4, 5
- Infected necrosis should be suspected in patients with persistent or worsening symptoms after 7-10 days of illness, and CT-guided fine-needle aspiration with culture and Gram stain should be performed to document infection 4, 5
Addressing the Alcohol Etiology
- Brief alcohol intervention during admission using the FRAMES model is recommended, which reduces alcohol consumption by approximately 41 g/week 1, 2
- Referral to alcohol counseling services and smoking cessation services is recommended during the same hospitalization 4, 5
Common Pitfalls to Avoid
- Surgery should not be performed for mild pancreatitis or severe pancreatitis with sterile necrosis, as it is only considered for infected necrosis 4, 5
- Patients should not be kept nil per os beyond 24 hours, as early oral feeding improves outcomes and shortens hospital stay 1, 2
- Parenteral nutrition should not be used if enteral feeding is possible, as enteral nutrition prevents gut failure and infectious complications 3